Lipoprotein(a) Levels and Apolipoprotein(a) Isoforms Related to Life Style Risk Factors

Journal of Epidemiology

Volumn 9, Issue 1, 1999, Pages 32-39

  Ishikawa, Shizukiyo ^a   Kayaba, Kazunori ^a   Igarashi, Masahiro ^a   Deguchi, Tomohiro ^b   Hara, Kazuo ^b   Takuma, Shuzo ^b   Tsutsumi, Akizumi ^c   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Akaike Town Hospital   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

apolipoprotein (a); cholesterol; fibrinogen; lipoprotein (a); smoking habit

Indexed keywords

APOLIPOPROTEIN A; ISOPROTEIN; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; BLOOD; ENVIRONMENT; FEMALE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HEALTH SURVEY; HUMAN; JAPAN; LIFESTYLE; MALE; MIDDLE AGED; PHENOTYPE; RISK FACTOR; SMOKING; STATISTICS;

ADULT; AGED; APOLIPOPROTEINS A; ENVIRONMENT; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; LIFE STYLE; LIPOPROTEIN(A); MALE; MIDDLE AGED; PHENOTYPE; POPULATION SURVEILLANCE; PROTEIN ISOFORMS; RISK FACTORS; SMOKING; STATISTICS;

EID: 0033069465     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.9.32     Document Type: Article

References (40)

1. Dahlen G, Ramberg UB. Pre-beta-1 lipoprotein and early detection of risk factors for coronary heart disease. Acta Med Scand 1974;195(5):341-4.
2. Berg K, Dahlen G, Frick MH. Lp(a) lipoprotein and pre-betal-lipoprotein in patients with coronary heart disease. Clin Genet 1974;6(3):230-5.
3. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;256(18):2540-4.
4. Jauhiainen M, Koskinen P, Ehnholm C, et al. Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants see comments. Atherosclerosis 1991;89(1):59-67.
5. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction [see comments.] JAMA 1993;270(18):2195-9.
6. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ 1990:301 (6763): 1248-51.
7. Sigurdsson G, Baldursdottir A, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfusson N. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol 1992:69 (16): 1251-4.
8. Cremer P, Nagel D, Labrot B, et al. Lipoprotein Lp (a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 1994;24 (7):444-53.
9. Bostom AG, Gagnon DR, Cupples LA, et al. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study, Circulation 1994;90 (4): 168895.
10. Schaefer EJ, Lamon-Fava S. Jenner JL, et al. Lipoprotein (a) levels and risk of coronaiy heart disea.se in men. The lipid Research Clinics Coronary Primary Prevention Trial see comments. JAMA 1994;271(13):999-1003.
11. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concenU-a-tions. J CUn Invest 1992;90 (52-60).
12. Albers JJ, Adolphson JL, Hazzard WR. Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res 1977;18:331-338.
13. Guyton JR, Dahlen GH, Patsch W, Kautz JA, Gotto J A. M. Relationship of plasma lipoprotein Lp(a) levels to race and to apoUpoprotein B. Arteiosclerosis 1985;5:265-72.
14. Zenker G, Koltringer P, Bone G, Niederkom K, Pfeiffer K, Jurgens G. Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke 1986;17(5):942-5.
15. TyrreU J, Cooke T, Reilly M, et al. Lipoprotein Lp(a). and peripheral vascular disease. J Intern Med 1992;232 (4):349-52.
16. Bruckert E, Davidoff P, Grimaldi A, et al. Increased serum levels of Upoprotein(a) in diabetes mellitus and their reduction with glycemic control. JAMA 1990; 263:35-6.
17. Parra HJ, Mezdour H, Cachera C, Dracon M, Tacquet A, Fruchart JC. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin Chem 1987;33:721.
18. Soma M, Fumagalli R, Meschia M, et al. Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women, (letter). Lancet I991;337:612.
19. Nago N, Kayaba K, Hiraoka J, et al. Lipoprotein(a) levels in the Japanese population: Influence of age and sex, and relational to atherosclerotic risk factors. The Jichi Medical School Cohort Study. Am J Epidemiol 1995;141:815-21.
20. Jenner JL, Ordovas JM, Lamon-Fava S, et al. Effects of age. sex, and menopausal status on plasma Upoprotein(a) levels. The Framingham Offspring Study. Circulation 1993;87(4):1135-41.
21. Hiraoka J, Nakamura Y, Yanagawa H, Nago N. Distribution of Upoprotein(a) and relationship between its level and blood chemical findings in a rural area in Japan. J Epidemiol 1994;4:163-9.
22. Matsuo H, Ohashi H. Hereditability of Lp(a) and other lipids in Japanese rural area Takasu.-JMS cohort study-. JpnCirc J 1994:58:528.
23. Utermann G, Menzel HJ. Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-Upoprotein concentrations in plasma. J Clin Invest 1987;80(2):458-65.
24. Utermann G, Hoppichler F, Dieplinger H, Seed M, Thompson G, Boerwinkle E. Defects in the LDL recepter gene affect Lp (a) lipoprotein levels: Multiplicative inter action of two gene loci associated with premature atherosclerosis. Proc Natl Acad Sci U S A 1989;86:4171-4.
25. Abe A, Noma A, Itakura H. Lipoprotein(a) phenotyping using a computerized micro scale and phenotype frequencies in a healthy Japanese population. Clin Chim Acta 1993;219 (1-2): 149-57.
26. Gotoh T, Kuroda T, Yamasawa M, et al. Correlation between hpoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol 1995;76(12):928-32.
27. Ishikawa S, Kario K, Nago N, et al. Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. Thromb Haemost 1997;77:890-3.
28. Klausen IC, Sjol A, Hansen PS, et al. Apolipoprotein(a) isoforms and coronary heart disease in men: a nested case-control study. Atherosclerosis 1997;132(1):77-84.
29. Sandholzer C, Saha N, Kark JD, et al. Apo(a) isoforms predict risk for coronary heart disease. A stody in six populations. Arterioscler Thromb 1992;12(10):1214-26.
30. Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermarm G. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Chn Invest 1992;89(3):1040-6.
31. Klausen IC, Beisiegel U, Menzel HJ, Rosseneu M, Nicaud V, Faergeman O. Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb Vase Biol 1995;15(8):1001-8.
32. Sandholzer C, Hallman DM, Saha N, et al. Effects of the apohpoprotein(a) size polymorphism on the lipoprotein (a) concentration in 7 ethnic groups. Hum Genet 1991;86(6):607-14.
33. Marcovina SM, Albers JJ, Jacobs D Jr., et al. Lipoproteina. concentrations and apoIipoproteina. phenotypes in Caucasians and African Americans. The CAR-DIA study. Arterioscler Thromb 1993;13(7): 1037-45.
34. Abe A, Noma A. Studies on apolipoprotein(a) phenotypes. Part 1. Phenotype frequencies in a healthy Japanese population. Atherosclerosis 1992;96(1):l-8.
35. Kark JD, Sandholzer C, Friedlander Y, Utermann G. Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population. Atherosclerosis 1993;98(2):139-51.
36. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto A Jr. Association of levels of lipoprotein Lp(a), plasma hpids, and other hpoproteins with coronary artery disease documented by angiography. Circulation 1986;74 (4):758-65.
37. Sechi LA, Kronenberg F, De-Carli S, et al. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension. JAMA 1997;277(21):1689-95.
38. Rader DJ, Cain W, Zech LA, Usher D, Brewer HBJ. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprtein(a) isoform is determined by the rate of lipoprtein(a) production. J Clin Invest 1993;91:443-447.
39. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient change of serum hpoprotein(a) as an acute phase protein. Atherosclerosis 1989;78:145-50.
40. Kawade M, Maeda S, Abe A, Yamashiro M. Alteration in plasma Lp(a) hpoprotein and acute phase protein after surgical poeration. Clin Chem 1984;30:941.